Iran's IRGC Navy says two tankers 'exploded' after hitting mines in Hormuz Reuters
Why IMMP Stock advanced +0.30% Today — RQD Quant Desk Flash
Immutep Limited (IMMP) carries a Roarable Rating of C- (Hold) with 60/100 RQD Confidence. The composite score sits in the neutral Hold band (59–69), meaning current holders don’t need to panic-sell while prospective buyers can wait for a move into the 70+ Buy zone.
Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer
FRED Regime × Technicals: 2% of 52W Range • RSI-14 at 23.1 (OVERSOLD (<32))
Altman Z-Score 3.80 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 7/9
Disciplined Float (-0.40% YoY Shares) & executive Form 4 sales trim 11 pts from alignment
⚔️ Adversarial Opposing Case: Why the IMMP Bull Thesis Could Fail
Even with a 60/100 (C-) score, IMMP faces multiple-compression risk if current valuation multiples re-rate toward historical sector medians or if hyperscaler/enterprise customer concentration slows in upcoming 10-Q filings.
Company executives have done more routine share selling than personal cash buying lately.
Dilution & Margin Drag: Disciplined Float (-0.40% YoY Shares) — any gross margin slip below 49.5% triggers an automatic RQD downgrade.
Technical & Forensic Kill-Switch: A daily close below the 50D SMA ($5.26) or 200D SMA ($16.96) invalidates the momentum regime and cuts Target Base ($3.36) toward Bear Floor ($2.62).
Why IMMP Stock advanced +0.30% Today — RQD Quant Desk Flash
Immutep Limited (IMMP) advanced +0.30% to $3.33, trading at 2% of its 52-week range ($3.04 – $70.6). Solid steady margins (steady margins), mixed timing at current multiples—hold if owned, no rush to chase.
- ▸Technical Tape: Trading at 2% of its 52-week range ($3.04 – $70.6) with RSI-14 at 23.1 (OVERSOLD (<32)).
- ▸Volatility Profile: Historical 20-day realized swing band of ±12.5% around $3.33 (no active unusual options sweep snapshot on file).
- ▸Fundamental Anchor: Roarable C- (Hold) backed by 52% gross margin and $687230 annual free cash flow.
The market could use a few victories in the days ahead, which will be filled with more earnings, an election, and jobs data.
Haley Stevens had lost the Democratic nomination for Senate in Michigan to Abdul El-Sayed earlier this year.
Israeli strikes kill eight people in Gaza - medics say Reuters
Russia's FSB says minor detained over park attack threat after US tip-off Reuters
Iran, Qatari mediators hold third day of talks to end US-Iran war Reuters
Qatar surges, bucking Gulf market slide on Iran war concerns Reuters
OPEC+ keeps December oil output targets steady ahead of tougher call for 2027 Reuters
Scheduled RQD Strong Buys & Whale Accumulation Briefing (IMMP Tape Review)
- ✓Breakdown of the highest-scoring RQD Green-Light breakouts across our 5,200+ rated universe
- ✓Forensic Red-Light accounting & dilution traps to review on your watchlist
- ✓Includes downloadable .ics calendar invite & nightly RQD rating-change email alerts
IMMP Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
vs. +6.0% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
No active Ellis Vennor swing setup published on IMMP today. View full Setup Ledger →
No direct multi-tier Butterfly edges indexed yet for IMMP. Explore sector supply chains on /butterfly.
📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (IMMP)
1. Head-to-Head Health Care Peer Comparison (IMMP vs. SHPH, MIRA, CRVO, ATOS)
Industry: Biotechnology: Pharmaceutical Preparations (489 Tracked Issuers)Across 1016 tracked Health Care securities in the Roarable RQD universe, Immutep Limited (IMMP) ranks #206 by composite RQD confidence (60/100, grade C-) and #820 by equity capitalization ($24.5M). Within this direct 5-issuer industry benchmark cohort, IMMP leads on earnings valuation at N/A trailing P/E, while SHPH leads on capital efficiency and profitability with -35.0% ROIC and — gross margin. IMMP currently leads its immediate peer cohort in composite quantitative strength at 60/100 (C-).
| Ticker / Company | Roarable Grade | RQD Score | Trailing P/E | Gross Margin | ROIC | 1D Change | Market Cap | Head-to-Head |
|---|---|---|---|---|---|---|---|---|
| IMMP
ACTIVE
Immutep Limited | C- | 60/100 | — | — | — | +0.30% | $24.5M | Benchmark Subject |
| SHPH Shuttle Pharmaceuticals Holdings Inc. | D | 46/100 | — | — | -35.0% | -0.19% | $24.9M | /shph-vs-immp → |
| MIRA MIRA Pharmaceuticals Inc. | D | 48/100 | — | — | -35.0% | +2.79% | $24.0M | /mira-vs-immp → |
| CRVO CervoMed Inc. | E | 29/100 | — | — | -35.0% | -20.81% | $26.5M | /crvo-vs-immp → |
| ATOS Atossa Therapeutics Inc. | D- | 36/100 | — | — | -35.0% | -5.91% | $22.3M | /atos-vs-immp → |
2. IMMP Fundamental Profitability, Capital Efficiency & Balance-Sheet Forensics
TRAILING 12M & FORWARD QUANTITATIVE SNAPSHOTImmutep Limited (IMMP) operates in Biotechnology: Pharmaceutical Preparations (Health Care) with an equity capitalization of $24.5M, trailing P/E of N/A, forward P/E of N/A, and EV/EBITDA of N/A. Operating profitability registers a gross margin of —, operating margin of —, net profit margin of —, ROIC of —, and free cash flow yield of —, alongside an Altman Z-Score of N/A and Piotroski F-Score of N/A.
3. IMMP Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)
✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLEDIs IMMP stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
As of 2026-11-01, Immutep Limited (NASDAQ: IMMP) is rated C- (Hold / HOLD) by Roarable's 5-pillar RQD engine with a composite confidence score of 60/100 at a spot price of $3.33 (+0.30% 1D, market cap $24.5M). Pillar breakdown: Fundamental Cash Engine 12/20, Institutional 13F & Options Flow 11/20, Executive Insider Alignment 13/20, FRED Macro Regime Fit 15/20, and SEC Balance-Sheet Forensics 9/20. Across 1016 tracked Health Care issuers, IMMP ranks #206 in composite RQD confidence.
How does IMMP compare to SHPH and MIRA in the Health Care sector?
Within the Health Care sector (Biotechnology: Pharmaceutical Preparations), IMMP carries a Roarable C- (60/100 RQD), trailing P/E of N/A, gross margin of —, and ROIC of —. By comparison, SHPH (Shuttle Pharmaceuticals Holdings Inc.) holds a D grade (46/100 RQD, P/E N/A, ROIC -35.0%, cap $24.9M) and MIRA (MIRA Pharmaceuticals Inc.) posts a D grade (48/100 RQD, P/E N/A, ROIC -35.0%, cap $24.0M). Among the 5-stock peer group, IMMP leads on earnings multiple (N/A) while SHPH leads on capital efficiency (-35.0% ROIC).
What are the biggest fundamental strengths and SEC risk factors for IMMP?
For Immutep Limited (IMMP), key quantitative strengths include Established market leader in Health Care with deep daily trading liquidity. and sector rank #206 in Health Care, while primary risk factors center on Company executives have done more routine share selling than personal cash buying lately. and implied 5-year growth hurdle of 8.0%/yr. Institutional options positioning shows a 50% call / 50% put premium split.
Where is IMMP trading relative to its 50-day, 200-day, and 52-week technical levels?
IMMP last traded at $3.33 (+0.30% on volume of 14,044 shares), positioning the stock -36.69% below its 50-day simple moving average ($5.26) and -80.37% below its 200-day simple moving average ($16.96). Across its 52-week range of $3.04 to $70.60, IMMP sits at the 0.4% percentile with a 14-day RSI of 23.1 (OVERSOLD (<32)) and an implied next-earnings move of ±12.5% ($2.91 to $3.75).
IMMP Investor FAQ & Complete 8-Part Research Index
100% OPEN ACCESS • SEC EDGAR × CBOE × FREDWhy is IMMP stock moving today?
Why IMMP Stock advanced +0.30% Today — RQD Quant Desk Flash. Solid steady margins (steady margins), mixed timing at current multiples—hold if owned, no rush to chase.